Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 Nov;31(11):1849–1851. doi: 10.1128/aac.31.11.1849

9-(trans-2',trans-3'-Dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine: analogs of neplanocin A which retain potent antiviral activity but exhibit reduced cytotoxicity.

M Hasobe 1, J G McKee 1, D R Borcherding 1, R T Borchardt 1
PMCID: PMC175052  PMID: 2449123

Abstract

Two synthetic analogs of neplanocin A, which were shown in a separate study to be inhibitors of S-adenosylhomocysteine hydrolase and devoid of substrate activity with adenosine kinase, were found in this study to inhibit vaccinia virus replication in murine L929 cells but to have reduced cytotoxicity compared with that of the parent compound. These results confirm that S-adenosylhomocysteine hydrolase is the molecular target which mediates the antiviral effects of neplanocin A and that transformation by cellular adenosine kinase mediates its cytotoxic properties.

Full text

PDF
1849

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berger S. L., Birkenmeier C. S. Inhibition of intractable nucleases with ribonucleoside--vanadyl complexes: isolation of messenger ribonucleic acid from resting lymphocytes. Biochemistry. 1979 Nov 13;18(23):5143–5149. doi: 10.1021/bi00590a018. [DOI] [PubMed] [Google Scholar]
  2. Borchardt R. T., Keller B. T., Patel-Thombre U. Neplanocin A. A potent inhibitor of S-adenosylhomocysteine hydrolase and of vaccinia virus multiplication in mouse L929 cells. J Biol Chem. 1984 Apr 10;259(7):4353–4358. [PubMed] [Google Scholar]
  3. De Clercq E. Antiviral and antimetabolic activities of neplanocins. Antimicrob Agents Chemother. 1985 Jul;28(1):84–89. doi: 10.1128/aac.28.1.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. De Clercq E., Cools M. Antiviral potency of adenosine analogues: correlation with inhibition of S-adenosylhomocysteine hydrolase. Biochem Biophys Res Commun. 1985 May 31;129(1):306–311. doi: 10.1016/0006-291x(85)91438-x. [DOI] [PubMed] [Google Scholar]
  5. Glazer R. I., Knode M. C. Neplanocin A. A cyclopentenyl analog of adenosine with specificity for inhibiting RNA methylation. J Biol Chem. 1984 Nov 10;259(21):12964–12969. [PubMed] [Google Scholar]
  6. Glazer R. I., Knode M. C., Tseng C. K., Haines D. R., Marquez V. E. 3-Deazaneplanocin A: a new inhibitor of S-adenosylhomocysteine synthesis and its effects in human colon carcinoma cells. Biochem Pharmacol. 1986 Dec 15;35(24):4523–4527. doi: 10.1016/0006-2952(86)90774-4. [DOI] [PubMed] [Google Scholar]
  7. Keller B. T., Borchardt R. T. Adenosine dialdehyde: a potent inhibitor of vaccinia virus multiplication in mouse L929 cells. Mol Pharmacol. 1987 May;31(5):485–492. [PubMed] [Google Scholar]
  8. Keller B. T., Clark R. S., Pegg A. E., Borchardt R. T. Purification and characterization of some metabolic effects of S-neplanocylmethionine. Mol Pharmacol. 1985 Oct;28(4):364–370. [PubMed] [Google Scholar]
  9. Shatkin A. J. Capping of eucaryotic mRNAs. Cell. 1976 Dec;9(4 Pt 2):645–653. doi: 10.1016/0092-8674(76)90128-8. [DOI] [PubMed] [Google Scholar]
  10. Ueland P. M. Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase. Pharmacol Rev. 1982 Sep;34(3):223–253. [PubMed] [Google Scholar]
  11. Yaginuma S., Muto N., Tsujino M., Sudate Y., Hayashi M., Otani M. Studies on neplanocin A, new antitumor antibiotic. I. Producing organism, isolation and characterization. J Antibiot (Tokyo) 1981 Apr;34(4):359–366. doi: 10.7164/antibiotics.34.359. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES